{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:00Z","timestamp":1761863640805},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1097\/md.0000000000005595","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T15:19:07Z","timestamp":1481210347000},"page":"e5595","source":"Crossref","is-referenced-by-count":10,"title":["Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients"],"prefix":"10.1097","volume":"95","author":[{"given":"Laia","family":"Sans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Radosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Quintian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Ble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Mojal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Ballarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fern\u00e1ndez-Llama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-79-20210226","doi-asserted-by":"crossref","first-page":"iv95","DOI":"10.1093\/ndt\/gfu186","article-title":"Spanish guidelines for the management of autosomal dominant polycystic kidney disease","volume":"29","author":"Ars","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R2-79-20210226","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjhyper.2004.06.020","article-title":"Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population","volume":"17","author":"Kelleher","year":"2004","journal-title":"Am J Hypertens"},{"key":"R3-79-20210226","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R4-79-20210226","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","article-title":"Use of antihypertensive medications and mortality of patients with autosomal dominant plycystic kidney disease: a population-based study","volume":"57","author":"Patch","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R5-79-20210226","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2014.120","article-title":"Analysis of data from ERA-EDTA registry indicates that conventional treatments for chronic kidney diseases do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease","volume":"86","author":"Spithoven","year":"2014","journal-title":"Kidney Int"},{"key":"R6-79-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R7-79-20210226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000101369","article-title":"Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function","volume":"27","author":"Borresen","year":"2007","journal-title":"Am J Nephrol"},{"key":"R8-79-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000339440","article-title":"Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients","volume":"36","author":"Kocyigit","year":"2012","journal-title":"Am J Nephrol"},{"key":"R9-79-20210226","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/003655998750015331","article-title":"Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease","volume":"32","author":"Martinez-Vea","year":"1998","journal-title":"Scand J Urol Nephrol"},{"key":"R10-79-20210226","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1797.2008.01049.x","article-title":"Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Rong","year":"2009","journal-title":"Nephrology (Carlton"},{"key":"R11-79-20210226","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2008.397","article-title":"Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension","volume":"74","author":"Cadnapaphornchai","year":"2008","journal-title":"Kidney Int"},{"key":"R12-79-20210226","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R13-79-20210226","first-page":"643","article-title":"Renal manifestations: complication management and long-term outcome of autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1991","journal-title":"Semin Nephrol"},{"key":"R14-79-20210226","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Gabow","year":"1990","journal-title":"Kidney Int"},{"key":"R15-79-20210226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R16-79-20210226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"R17-79-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2015.71","article-title":"A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease","volume":"88","author":"Bhutani","year":"2015","journal-title":"Kidney Int"},{"key":"R18-79-20210226","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"R19-79-20210226","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"R20-79-20210226","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"R21-79-20210226","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MNH.0b013e32834ba210","article-title":"Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation?","volume":"20","author":"Madero","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R22-79-20210226","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.ajkd.2004.04.026","article-title":"Exercise blood pressure, card\u00edac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state","volume":"44","author":"Martinez-Vea","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R23-79-20210226","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"R24-79-20210226","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"R25-79-20210226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000355756","article-title":"Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease","volume":"38","author":"Raptis","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"R26-79-20210226","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"R27-79-20210226","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"key":"R28-79-20210226","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"key":"R29-79-20210226","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"R30-79-20210226","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"R31-79-20210226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","article-title":"Analysis of baseline parameters in the HALT polycystic kidney disease trials","volume":"81","author":"Torres","year":"2012","journal-title":"Kidney Int"},{"key":"R32-79-20210226","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med"},{"key":"R33-79-20210226","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-79-20210226","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.08.026","article-title":"Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)","volume":"46","author":"O\u2019Neill","year":"2005","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T17:10:17Z","timestamp":1657991417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201612060-00079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005595","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}